IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed Aug 10, 2023 · 10-Q · 41 days after period end · 0000950170-23-041482
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$7.72M | -$7.18M | -$3.05M | -$2.87M |
| EPS Diluted | -$0.27 | -$0.38 | -$1.00 | -$0.92 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 10, 2023 · 41 d after period end
